Results 111 to 120 of about 16,551 (199)

Reply to Trosch et al. Comment on "Dashtipour et al. Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information. <i>Toxins</i> 2024, <i>16</i>, 442". [PDF]

Toxins (Basel)
Dashtipour K, Lee HS, Ellenbogen A, Kazerooni R, Gross TM, Hollander DA, Gallagher CJ.   +6 more
europepmc   +1 more source

Enolase and 16.5‐kDa Tegument‐Associated Protein in Fasciola hepatica Extracellular Vesicles: Clues to Their Role in Pathogenesis

Journal of Extracellular Biology, Volume 4, Issue 6, June 2025.
Recombinant enolase and 16.5 tegumentary proteins from F. hepatica EVs may influence the progression of fibrosis, altering cell growth, proteomic profiles, and EVs secretion in macrophages, hepatic stellate cells (HSCs) and hepatocytes. r‐Fhenolase reduced fibrosis markers in HSCs and exhibited anti‐inflammatory properties in macrophages, and r‐Fh16 ...
Aránzazu González‐Arce, Christian M. Sánchez‐López, Liz F. Sánchez‐Palencia, Antonio Marcilla, Dolores Bernal   +4 more
wiley   +1 more source

Preclinical Evaluation of Botulinum Toxin Type E (TrenibotulinumtoxinE) Using the Mouse Digit Abduction Score (DAS) Assay. [PDF]

Toxins (Basel)
Nicholson GS, Canty D, Southern A, Whelan K, Brideau-Andersen AD, Broide RS.   +5 more
europepmc   +1 more source

The Interconnected World of Dermatology and Ophthalmology

JEADV Clinical Practice, Volume 4, Issue 2, Page 389-399, June 2025.
Medical science, is an integrated field that shares intricate relationship between various organ systems. Similarly, dermatology is inter‐related with various other specialties including ophthalmology. This article depicts the correlation of ophthalmology and dermatology iterating on the genetic diseases, autoimmune diseases, systemic disorders ...
Gyanesh Rathore, Surajit Gorai, Gitikash Purkayastha, Kinnor Das, Prajwal Pudasaini   +4 more
wiley   +1 more source

Autonomic Dysfunction and Blood Pressure Variability in Botulinum Intoxication: A Prospective Observational Study from a Single-Center Italian Outbreak. [PDF]

Toxins (Basel)
Miceli G, Cassataro G, Volpe V, Fertitta E, Canale C, Tomaiuolo L, Blasco M, Stella M, Velardo M, Renda M.   +9 more
europepmc   +1 more source

The Effect of Corticosteroid Doses on Pain in Knee Osteoarthritis: A Systematic Review and Meta‐Analysis

Musculoskeletal Care, Volume 23, Issue 2, June 2025.
ABSTRACT Objective To evaluate the effect of various doses of intra articular corticosteroid injection (IACI) on pain reduction in knee osteoarthritis when compared with normal saline and perform a between‐dose comparison. Methods A systematic review with meta‐analysis was conducted searching four databases until April 2024.
Marc‐Antoine Lafrenaye‐Dugas, Frédérique Dupuis, Valérie Bélanger, Marie‐Michèle Briand   +3 more
wiley   +1 more source

Comment on Dashtipour et al. Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information. <i>Toxins</i> 2024, <i>16</i>, 442. [PDF]

Toxins (Basel)
Trosch R, Parreirinha D, Proeschel S.
europepmc   +1 more source

CORONIS symposium 2023: Scientific and clinical frontiers in ocular surface innervation

Acta Ophthalmologica, Volume 103, Issue 4, Page e240-e255, June 2025.
Abstract The 5th CORONIS Symposium, held during the 2023 Congress of the European Association for Vision and Eye Research (EVER), highlighted the growing importance of ocular surface innervation in eye surface disorders. This article summarises the insights and perspectives shared during the symposium, which focused on the clinical relevance of ocular ...
Anat Galor, Juana Gallar, M. Carmen Acosta, Víctor Meseguer, José Manuel Benítez‐Del‐Castillo, Oliver Stachs, Nóra Szentmáry, Piera Versura, Wolfgang G. K. Müller‐Lierheim, Carlos Belmonte, Jesús Pujol‐Martí   +10 more
wiley   +1 more source

Botulinum Toxin in Pain-Related Post-Stroke Limb Spasticity: A Meta-Analysis of Early and Late Injections. [PDF]

Toxins (Basel)
Tamayo FM, Rosales R, Wissel J, Biering-Sørensen B, Ellano JN, Simpson D.   +5 more
europepmc   +1 more source

Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database‐based observational cohort study

Headache: The Journal of Head and Face Pain, Volume 65, Issue 6, Page 919-932, June 2025.
Abstract Objective To estimate the real‐world risk of cardiovascular events among patients with migraine treated with erenumab and other migraine preventive medications. Background Migraine preventive treatment with calcitonin gene‐related peptide (CGRP) pathway inhibitors, such as erenumab and others, may theoretically result in cardiovascular effects
David W. Dodick, Stewart J. Tepper, Jessica Ailani, Ani C. Khodavirdi, Nico Pannacciulli, Alan Fu, Shia T. Kent, Karminder Gill, Robert Urman, Sam S. Oh   +9 more
wiley   +1 more source